ISRG Intuitive Surgical Inc.

Intuitive Announces Board of Directors Elections and Retirements

Intuitive Announces Board of Directors Elections and Retirements

Lewis Chew elected to Intuitive’s Board

Alan Levy, PhD and Don Kania, PhD to retire from Board

SUNNYVALE, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that Lewis Chew, former chief financial officer at Dolby Labs, Inc., has been elected to the Company’s Board of Directors, effective April 25.

“Lewis brings decades of experience across global organizations, technologies, and complex supply chains that will be a good fit for Intuitive’s Board,” said Gary Guthart, Intuitive CEO. “His insights and expertise will serve Intuitive well as we continue expansion and enhancement of minimally invasive care.”

Chew, 61, served as CFO at Dolby Labs, Inc. from June 2012 to October 2021. Previously, he was CFO at National Semiconductor Corporation from April 2001 to September 2011 and a partner at KPMG from 1995 to 1997. From September 2009 to April 2019, Chew served on the Board of Directors of PG&E Company.

He is currently a director on the boards of Cadence Design Systems, Inc. and Arista Networks, Inc. and continues to serve on the Accounting Advisory Board of Santa Clara University, a position he has held since 1995.

Business publisher Institutional Investor named Chew one of the Best CFOs in America, the National Diversity Council included him in its list of Top 50 Multicultural Leaders, and the U.S. Pan Asian American Chamber of Commerce recognized him with its Corporate Director Award. He received a Bachelor of Science in Accounting from Santa Clara University.

Separately, two Intuitive board members, Alan Levy, Ph.D., and Don Kania, Ph.D., have retired from the Company’s Board effective at the expiration of their terms on April 25, 2024.

“It has been an honor to serve on Intuitive’s Board for over two decades as the company has become the leader in life-enhancing, minimally invasive care,” said Levy. “I look forward to seeing Intuitive drive forward the next generation of robotic-assisted surgery and continue to help millions of patients around the world.”

“It has been a privilege to experience Intuitive’s dedication to innovation up close as a member of its Board,” said Kania. “Intuitive is well positioned to continue providing customers with cutting-edge technology that will further enhance the future of care.”

Levy has served as a member of the Board since February 2000 and previously held a role as the independent lead director from April 2013 to 2018. Mr. Kania has served as a member of the Board since July 2017.

“On behalf of the Intuitive team, I am grateful for Alan and Don’s invaluable service, expertise, and passion for improving patient care,” said Guthart. “Their decades of combined service have helped us advance to where we are today, and they will be missed.”

About Intuitive Surgical, Inc.

Intuitive (NASDAQ:ISRG), headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most.

About da Vinci Surgical Systems

There are several models of the da Vinci Surgical System. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery and offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels and forceps) that are designed to help with precise dissection and reconstruction deep inside the body.

For more information, please visit the company’s website at

Important Safety Information

For Important Safety Information, indications for use, risks, full cautions, and warnings, please refer to the associated da Vinci user manual(s).

Contact

Global Public Affairs

Intuitive Surgical



1-202-997-7373



EN
25/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Intuitive Surgical Inc.

 PRESS RELEASE

Intuitive Expands Investment and Footprint in Europe

Intuitive Expands Investment and Footprint in Europe Company begins direct operations in Italy, Spain, Portugal, Malta, San Marino, and associated territories SUNNYVALE, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the completion of its acquisition of the da Vinci and Ion distribution business operated by ab medica, Abex, Excelencia Robótica, and their affiliates. The completion marks the formal expansion of Intuitive’s direct operations in Europe, e...

 PRESS RELEASE

Da Vinci 5 Cleared for Cardiac Procedures

Da Vinci 5 Cleared for Cardiac Procedures FDA 510(k) clearance expands da Vinci 5 indications to include certain cardiac procedures SUNNYVALE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food and Drug Administration (FDA) has cleared the da Vinci 5 system for certain cardiac procedures, including mitral valve repair and IMA (internal mammary artery) mobilization for cardiac revascularization.         Cardiovascular disease remains the l...

 PRESS RELEASE

20 Million Patients Benefit from da Vinci Surgery Globally

20 Million Patients Benefit from da Vinci Surgery Globally Achievement reflects the dedication of surgeons and care teams worldwide to improving patient outcomes through use of Intuitive’s minimally invasive technologies SUNNYVALE, Calif., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced that more than 20 million patients worldwide have been operated on by surgeons using da Vinci surgical systems. The milestone was reached as of the end of 2025, with more than 3.1 mil...

 PRESS RELEASE

Intuitive Announces Fourth Quarter Earnings

Intuitive Announces Fourth Quarter Earnings SUNNYVALE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2025. Q4 Highlights Worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew approximately 44%.The Company placed 532 da Vinci surgical systems, compared with...

 PRESS RELEASE

Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Resu...

Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results SUNNYVALE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2025 financial results ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. Financial and Operational Highlights Fourth quarter 2025 worldwide procedures (da Vinci and Ion combined) grew approximately 18...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch